FDA
The research and development (R D) process for a new drug takes an average of 10 to 15 years and involves many discrete steps and activities.
A look at the FDA and regulation of vitamins in the United States is revealing for the pharmacist.
For all the hoopla and noise being made by the two presidential hopefuls over the state of our health care, there is not much talk about life expectancy in the United States compared with that in other countries.
Have you ever wondered how well the FDA is doing at protecting the American public from harmful drugs?
Alexandria, VA -- A survey conducted by the American Society of Health-System Pharmacists (ASHP) uncovered that the number of health system pharmacists playing a significant role in consulting with physicians on a wide range of drug protocols increased by 2% over the past six years.
The sorcerer leaves his apprentice alone in the workshop tidying up...
FDA Releases Stent Recommendations The FDA has issued draft guidelines to aid the development, testing, and manufacture of coronary drug-eluting stents, devices for treating blocked heart arteries...
Although the first sunscreen product was developed in 1928, it was not until the 1940s that the FDA began to regulate these products.
Imagine that a family member is suffering from a horrible disease that has no apparent treatment.
Prison Sentences for Women Who Claimed ALS Cure The FDA Office of Criminal Investigations today announced that a New Jersey woman has been sentenced to 33 months in prison for falsely claiming that she could cure amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease.
At the behest of the FDA, U.S. Marshals seized more than $300,000 worth of products, including an antifungal product sold as NC Solution, other drugs for human or animal use, dietary supplements, and ingredients of those products.
FDA Halts Marketing of Unapproved Hydrocone Products Companies marketing unapproved drug products containing the narcotic hydrocone must cease or they will be subject to enforcement action, the FDA announced.
FDA Warns Melanotan II Maker The FDA issued a Warning Letter to Brian Manookian, owner of Melanocorp, Inc.
NCPA: CMS Downplaying Effect of New Medicaid Reimbursement Rule Alexandria, Va.
Planning for Flu Outbreaks The FDA issued final recommendations for increasing the supply of safe and effective influenza vaccines for both seasonal and pandemic use.
Online Counterfeit Drug Concerns
FDA Moves to Stop Marketing of Nausea and Vomiting Drug The FDA announced that companies must cease manufacturing and distributing unapproved suppository drug products containing trimethobenzamide hydrochloride.
Xolair to Get Black Box Warning The FDA requested that Genentech, Inc.
FDA to Strengthen Drug Safety The FDA has made recommendations to Congress for the next reauthorization of the Prescription Drug User Fee program that are designed to broaden and upgrade the agency's drug safety program, increase resources for review of television drug advertising, and facilitate more efficient development of safe and effective new medications for the American public.
Warnings Issued Regarding Rituxan Safety Concern in New Patient Population The FDA is alerting health care professionals and patients treated with Rituxan (rituximab), manufactured by Genentech, to reports of an emerging risk of a serious side effect.